Published • loading... • Updated
Boston Scientific Drops 16%. Next Up: Monday's Watchman Reaction
Summary by ts2.tech
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Boston Scientific Drops 16%. Next Up: Monday's Watchman Reaction
Boston Scientific shares plunged 16.4% last week, closing at $48.31 on May 29 after CEO Michael Mahoney flagged “declining usage” of the Watchman heart implant and forecast flat growth through Q3. Wells Fargo downgraded the stock, slashing its target to $55. Friday’s volume nearly doubled the 50-day average as rivals Abbott and Medtronic ramped up competition. A $2 billion buyback is underway, with results next due July 29. The post Boston Scien…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
